A framework of biomarkers for skeletal muscle aging: a consensus statement by the Aging Biomarker Consortium

Abstract

The skeletal muscle is an important organ for movement and metabolism in human body, and its physiological aging underlies the occurrence of muscle atrophy and sarcopenia. China has the largest aging population in the world and is facing a grand challenge with how to prevent and treat skeletal muscle aging-related diseases. To address this difficult problem, the Aging Biomarker Consortium (ABC) of China has reached an expert consensus on biomarkers of skeletal muscle aging by synthesizing literatures and insights from scientists and clinicians. This consensus attempts to provide a comprehensive assessment of biomarkers associated with skeletal muscle aging, and proposes a systematic framework to classify them into three dimensions: functional, structural, and humoral. Within each dimension, the experts recommend clinically relevant biomarkers for skeletal muscle aging. This consensus aims to lay the foundation for future research on skeletal muscle aging, facilitating precise prediction, diagnosis, and treatment of skeletal muscle aging and sarcopenia. It is anticipated to make significant contributions to healthy aging of skeletal muscle in the elderly population in China and around the world as well.

References

[1] Dao T , Green AE , Kim YA , et al. Sarcopenia and muscle aging: a brief overview. Endocrinol Metab (Seoul, Korea) 2020; 35: 716- 32.

[2] Larsson L , Degens H , Li M , et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev 2019; 99: 427- 511.

[3] Cruz-Jentoft AJ , Sayer AA . Sarcopenia. Lancet (London, England) 2019; 393: 2636- 46.

[4] china, N. b. o. s. o. Statistical Communiqué of the People’s Republic of China on the 2023 National Economic And Social Development. 2023. China Statistics Press.

[5] Lexell J . Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 1995; 50 Spec No: 11- 6.

[6] Naruse M , Trappe S , Trappe TA . Human skeletal muscle-specific atrophy with aging: a comprehensive review. J Appl Physiol (Bethesda, Md.: 1985) 2023; 134: 900- 14.

[7] Grosicki GJ , Zepeda CS , Sundberg CW . Single muscle fibre contractile function with ageing. J Physiol 2022; 600: 5005- 26.

[8] Sousa-Victor P , García-Prat L , Muñoz-Cánoves P . Control of satellite cell function in muscle regeneration and its disruption in ageing. Nat Rev Mol Cell Biol 2022; 23: 204- 26.

[9] Mancinelli R , Checcaglini F , Coscia F , et al. Biological aspects of selected myokines in skeletal muscle: focus on aging. Int J Mol Sci 2021; 22: 8520.

[10] Bao H , Cao J , Chen M , et al; Aging Biomarker Consortium. Biomarkers of aging. Sci China Life Sci 2023; 66: 893- 1066.

[11] Cai Y , Song W , Li J , et al. The landscape of aging. Sci China Life Sci 2022; 65: 2354- 454.

[12] Ren J , Song M , Zhang W , et al. The Aging Biomarker Consortium represents a new era for aging research in China. Nat Med 2023; 29: 2162- 5.

[13] Aging Biomarker C et al. A framework of biomarkers for brain aging: a consensus statement by the Aging Biomarker Consortium. Life Med. 2023; 2: lnad017.

[14] Aging Biomarker C et al. A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement. Life Med. 2024; 3: lnae004.

[15] Aging Biomarker C et al. A framework of biomarkers for skeletal aging: a consensus statement by the Aging Biomarker Consortium. Life Med. 2023; 2: lnad045.

[16] Aging Biomarker C et al. A framework of biomarkers for vascular aging: a consensus statement by the Aging Biomarker Consortium. Life Med. 2023; 2: lnad033.

[17] Aging Biomarker C et al. A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement. Life Med. 2023; 2: lnad035.

[18] Frontera WR , Ochala J . Skeletal muscle: a brief review of structure and function. Calcif Tissue Int 2015; 96: 183- 95.

[19] Weineck J . Weineck J. Functional anatomy in sports 1986;1. Published in December 19, 2016.

[20] Brown LE . National Strength and Conditioning Associaiton(NSCA).-Strength training. 2016.

[21] Thistle HG , Hislop HJ , Moffroid M , et al. Isokinetic contraction: a new concept of resistive exercise. Arch Phys Med Rehabil 1967; 48: 279- 82.

[22] Mehmet H , Yang AWH , Robinson SR . Measurement of hand grip strength in the elderly: a scoping review with recommendations. J Bodywork Mov Ther 2020; 24: 235- 43.

[23] Chen LK , Woo J , Assantachai P , et al. Asian Working Group for sarcopenia: 2019 Consensus Update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020; 21: 300- 7.e2.

[24] Massy-Westropp N , Rankin W , Ahern M , et al. Measuring grip strength in normal adults: reference ranges and a comparison of electronic and hydraulic instruments. J Hand Surg 2004; 29: 514- 9.

[25] Cruz-Jentoft AJ , Bahat Gϋlistan , Bauer Jϋrgen , et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601.

[26] Patrizio E , Calvani R , Marzetti E , et al. Physical functional assessment in older adults. J Frailty Aging 2021; 10: 141- 9.

[27] Guralnik JM , Simonsick EM , Ferrucci L , et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49: M85- 94.

[28] Chinese Association of Geriatric Reasearch Aging Health Services and Standardization Branch . Expert consensus on fall risk assessment in Chinese elderly (Draft). Chin J Geriatr Care 2019; 17: 2.

[29] Shou J , Chen PJ , Xiao WH . Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetol Metab Syndr 2020; 12: 14.

[30] Meneilly GS , Elliott T , Tessier D , et al. NIDDM in the elderly. Diabetes Care 1996; 19: 1320- 5.

[31] Cleasby ME , Jamieson PM , Atherton PJ . Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 2016; 229: R67- 81.

[32] Houmard JA , Weidner MD , Dolan PL , et al. Skeletal muscle GLUT4 protein concentration and aging in humans. Diabetes 1995; 44: 555- 60.

[33] Frandsen J , Sahl RE , Rømer T , et al. Extreme duration exercise affects old and younger men differently. Acta Physiol (Oxf) 2022; 235: e13816.

[34] Widajanti, N , Soelistijo SA , Hadi U , et al. Association between sarcopenia and insulin-like growth factor-1, myostatin, and insulin resistance in elderly patients undergoing hemodialysis. J Aging Res 2022; 2022: 1327332.

[35] Du Y , Oh C , No J . Associations between sarcopenia and metabolic risk factors: a systematic review and meta-analysis. J Obes Metab Syndr 2018; 27: 175- 85.

[36] Poggiogalle E , Lubrano C , Gnessi L , et al. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity. Clin Nutr (Edinburgh, Scotland) 2019; 38: 2430- 5.

[37] Park JH , Lee M-Y , Shin H-K , et al. Lower skeletal muscle mass is associated with diabetes and insulin resistance: a cross-sectional study. Diabetes Metab Res Rev 2023; 39: e3681.

[38] Feige P , Rudnicki MA . Muscle stem cells. Curr Biol 2018; 28: R589- 90.

[39] Verdijk LB , Snijders T , Drost M , et al. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordrecht, Netherlands) 2014; 36: 545- 7.

[40] Benjamin DI , Brett JO , Both P , et al. Multiomics reveals glutathione metabolism as a driver of bimodality during stem cell aging. Cell Metab 2023; 35: 472- 86.e6.

[41] Li H , Chen Q , Li C , et al. Muscle-secreted granulocyte colony-stimulating factor functions as metabolic niche factor ameliorating loss of muscle stem cells in aged mice. EMBO J 2019; 38: e102154.

[42] Porpiglia E , Mai T , Kraft P , et al. Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration. Cell Stem Cell 2022; 29: 1653- 68.e8.

[43] Dodds R , Sayer AA . Sarcopenia and frailty: new challenges for clinical practice. Clin Med (London, England) 2015; 15: s88- 91.

[44] Dennison EM , Sayer AA , Cooper C . Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol 2017; 13: 340- 7.

[45] Perkisas S , Bastijns S , Baudry S , et al. Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. Eur Geriatr Med 2021; 12: 45- 59.

[46] Kirkham BM , Schultz SM , Ashi K , et al. Assessment of age-related oxygenation changes in calf skeletal muscle by photoacoustic imaging: a potential tool for peripheral arterial disease. Ultrason Imaging 2019; 41: 290- 300.

[47] Shorter E , Sannicandro AJ , Poulet B , et al. Skeletal muscle wasting and its relationship with osteoarthritis: a mini-review of mechanisms and current interventions. Curr Rheumatol Rep 2019; 21: 40.

[48] Larsson L , Sjödin B , Karlsson J . Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22--65 years. Acta Physiol Scand 1978; 103: 31- 9.

[49] Giresi PG , Stevenson EJ , Theilhaber J , et al. Identification of a molecular signature of sarcopenia. Physiol Genomics 2005; 21: 253- 63.

[50] Young A , Stokes M , Crowe M . Size and strength of the quadriceps muscles of old and young women. Eur J Clin Invest 1984; 14: 282- 7.

[51] Rice CL , Cunningham DA , Paterson DH , et al. Arm and leg composition determined by computed tomography in young and elderly men. Clin Physiol (Oxford, England) 1989; 9: 207- 20.

[52] Lexell J . Ageing and human muscle: observations from Sweden. Can J Appl Physiol = Revue canadienne de physiologie appliquee 1993; 18: 2- 18.

[53] Yang Y , Lu X , Liu N , et al. Metformin decelerates aging clock in male monkeys. Cell 2024; 187: 6358- 78.e29.

[54] Jing Y , Zuo Y , Yu Y , et al. Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging. Protein Cell 2022; 14: pwac061.

[55] Solomon A , Bouloux P . Endocrine therapies for sarcopenia in older men. Br J Hosp Med (Lond) 2006; 67: 477- 81.

[56] Wu Z , Lu M , Liu D , et al. m6A epitranscriptomic regulation of tissue homeostasis during primate aging. Nature Aging 2023; 3: 705- 21.

[57] Kim JK , Gimeno RE , Higashimori T , et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 2004; 113: 756- 63.

[58] Zoico E , Rossi A , Di Francesco V , et al. Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci 2010; 65: 295- 9.

[59] Chianca V , Albano D , Rizzo S , et al. Inter-vendor and inter-observer reliability of diffusion tensor imaging in the musculoskeletal system: a multiscanner MR study. Insights Imaging 2023; 14: 32.

[60] Kuswanto W , Burzyn D , Panduro M , et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, Interleukin-33-dependent accumulation of regulatory T cells. Immunity 2016; 44: 355- 67.

[61] Chazaud B . Inflammation and skeletal muscle regeneration: leave it to the macrophages! Trends Immunol 2020; 41: 481- 92.

[62] May DA , Disler DG , Jones EA , et al. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000; 20 Spec No: S295- 315.

[63] Rashidian M , Keliher EJ , Bilate AM , et al. Noninvasive imaging of immune responses. Proc Natl Acad Sci USA 2015; 112: 6146- 51.

[64] Loomis T , Smith LR . Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis. Am J Physiol Cell Physiol 2023; 325: C895- 906.

[65] Lieber RL , Ward SR . Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis. Am J Physiol Cell Physiol 2013; 305: C241- 252.

[66] Mahdy MAA . Skeletal muscle fibrosis: an overview. Cell Tissue Res 2019; 375: 575- 88.

[67] Lenchik L , Mazzoli V , Cawthon PM , et al. Muscle steatosis and fibrosis in older adults, from the AJR special series on imaging of fibrosis. AJR Am J Roentgenol 2024; 222: e2329742.

[68] Oudeman J , Nederveen AJ , Strijkers GJ , et al. Techniques and applications of skeletal muscle diffusion tensor imaging: a review. J Magn Reson Imaging : JMRI 2016; 43: 773- 88.

[69] Tintignac LA , Brenner HR , Rüegg MA . Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev 2015; 95: 809- 52.

[70] Li L , Xiong WC , Mei L . Neuromuscular junction formation, aging, and disorders. Annu Rev Physiol 2018; 80: 159- 88.

[71] Lee G , Lim JY , Frontera WR . Apoptosis in young and old denervated rat skeletal muscle. Muscle Nerve 2017; 55: 262- 9.

[72] Carlson BM . The biology of long-term denervated skeletal muscle. Eur J Trans Myol 2014; 24: 3293.

[73] Jones RA , Harrison C , Eaton SL , et al. Cellular and molecular anatomy of the human neuromuscular junction. Cell reports 2017; 21: 2348- 56.

[74] Jang YC , Van Remmen H . Age-associated alterations of the neuromuscular junction. Exp Gerontol 2011; 46: 193- 8.

[75] Sanders DB , Arimura K , Cui LY , et al. Guidelines for single fiber EMG. Clin Neurophysiol 2019; 130: 1417- 39.

[76] Badawi Y , Nishimune H . Impairment mechanisms and intervention approaches for aged human neuromuscular junctions. Front Mol Neurosci 2020; 13: 568426.

[77] Gonzalez-Freire M , de Cabo R , Studenski SA , et al. The neuromuscular junction: aging at the crossroad between nerves and muscle. Front Aging Neurosci 2014; 6: 208.

[78] He Y , Xie W , Li H , et al. Cellular senescence in sarcopenia: possible mechanisms and therapeutic potential. Front Cell Dev Biol 2021; 9: 793088.

[79] Zhang X , Habiballa L , Aversa Z , et al. Characterization of cellular senescence in aging skeletal muscle. Nature aging 2022; 2: 601- 15.

[80] da Costa Teixeira LA , Avelar NCP , Peixoto MFD , et al. Inflammatory biomarkers at different stages of Sarcopenia in older women. Sci Rep 2023; 13: 10367.

[81] Ha H , Debnath B , Neamati N . Role of the CXCL8-CXCR1/2 Axis in cancer and inflammatory diseases. Theranostics 2017; 7: 1543- 88.

[82] Liang R , Qi X , Cai Q , et al. The role of NLRP3 inflammasome in aging and age-related diseases. Immun Ageing: I & A 2024; 21: 14.

[83] Li CW , Yu K , Shyh-Chang N , et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle 2019; 10: 586- 600.

[84] Yin P , Chen M , Rao M , et al. Deciphering immune landscape remodeling unravels the underlying mechanism for synchronized muscle and bone aging. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2304084.

[85] Picca A , Coelho-Junior HJ , Calvani R , et al. Biomarkers shared by frailty and sarcopenia in older adults: a systematic review and meta-analysis. Ageing Res Rev 2022; 73: 101530.

[86] Chen X , Li Y . Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis. Cell adh Migr 2009; 3: 337- 41.

[87] Tada M , Yamada Y , Mandai K , et al. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis - results from the CHIKARA study. Int J Rheumatic Dis 2018; 21: 1962- 9.

[88] Suzan V , Yavuzer H , Bag Soytas R , et al. The relationship between primary sarcopenia and SARC-F, serum MMP9, TIMP1 levels, and MMP9/TIMP1 ratio in the geriatric patients. Eur Geriatr Med 2021; 12: 1229- 35.

[89] Asoudeh F , Dashti F , Raeesi S , et al. Inflammatory cytokines and sarcopenia in Iranian adults-results from SARIR study. Sci Rep 2022; 12: 5471.

[90] Franceschi C , Bonafè M , Valensin S , et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244- 54.

[91] Fujie S , Sato K , Miyamoto-Mikami E , et al. Reduction of arterial stiffness by exercise training is associated with increasing plasma apelin level in middle-aged and older adults. PLoS One 2014; 9: e93545.

[92] Vinel C , Lukjanenko L , Batut A , et al. The Exerkine Apelin reverses age-associated sarcopenia. Nat Med 2018; 24: 1360- 71.

[93] Sanchez-Sanchez JL , He L , Virecoulon Giudici K , et al. Circulating levels of Apelin, GDF-15 and sarcopenia: lack of association in the MAPT Study. J Nutr Health Aging 2022; 26: 564- 70.

[94] Guo M , Yao J , Li J , et al. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction. J Cachexia Sarcopenia Muscle 2023; 14: 391- 405.

[95] Zhang H , Wu X , Liang J , et al. Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res Rev 2022; 80: 101680.

[96] Chang JS , Kim TH , Nguyen TT , et al. Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study. Geriatr & Gerontol Int 2017; 17: 2266- 73.

[97] Baek JY , Jang I-Y , Jung H-W , et al. Serum Irisin level is independent of sarcopenia and related muscle parameters in older adults. Exp Gerontol 2022; 162: 111744.

[98] Yarasheski KE , Bhasin S , Sinha-Hikim I , et al. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 2002; 6: 343- 8.

[99] Bergen HR 3rd , Farr JN , Vanderboom PM , et al. Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay.Skeletal muscle 2015; 5: 21.

[100] Pedersen BK . Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol 2019; 15: 383- 92.

[101] Kalinkovich A , Livshits G . Sarcopenia--The search for emerging biomarkers. Ageing Res Rev 2015; 22: 58- 71.

[102] Erickson KI , Prakash RS , Voss MW , et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010; 30: 5368- 75.

[103] Kwak JY , Hwang H , Kim S-K , et al. Prediction of sarcopenia using a combination of multiple serum biomarkers. Sci Rep 2018; 8: 8574.

[104] Volpato S , Bianchi L , Cherubini A , et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014; 69: 438- 46.

[105] Tseng SH , Lee WJ , Peng LN , et al. Associations between hemoglobin levels and sarcopenia and its components: results from the I-Lan longitudinal study. Exp Gerontol 2021; 150: 111379.

[106] Silva-Fhon JR , Rojas-Huayta VM , Aparco-Balboa JP , et al. Sarcopenia and blood albumin: a systematic review with meta-analysis. Biomed: Rev del Instituto Nacional de Salud 2021; 41: 590- 603.

[107] Yin M , Zhang H , Liu Q , et al. Diagnostic performance of clinical laboratory indicators with sarcopenia: results from the West China Health and Aging Trend Study. Front Endocrinol 2021; 12: 785045.

[108] Wu C , Wang Q , Zhou C-Y , et al. Association of AST/ALT (De Ritis) ratio with sarcopenia in a Chinese population of community-dwelling elderly. Heliyon 2023; 9: e20427.

[109] Sala D , Sacco A . Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases. Curr Opin Clin Nutr Metab Care 2016; 19: 171- 6.

[110] Martyn JAJ , Kaneki M . Muscle atrophy and the sestrins. N Engl J Med 2020; 383: 1279- 82.

[111] Segalés J , Perdiguero E , Serrano AL , et al. Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals. Nat Commun 2020; 11: 189.

[112] Zeng N , D’Souza RF , Mitchell CJ , et al. Sestrins are differentially expressed with age in the skeletal muscle of men: a cross-sectional analysis. Exp Gerontol 2018; 110: 23- 34.

[113] Fu Y , Tao L , Wang X , et al. PGC-1α participates in regulating mitochondrial function in aged sarcopenia through effects on the Sestrin2-mediated mTORC1 pathway. Exp Gerontol 2024; 190: 112428.

[114] Jing Y , Zuo Y , Sun L , et al. SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. Cell Prolif 2023; 56: e13455.

[115] Zhao Q , Jing Y , Ma S , et al. An efficient protocol for studying human pluripotent stem cell-derived myotube senescence. Biophys Rep 2023; 9: 232- 40.

[116] Shigehara K , Kato Y , Izumi K , et al. Relationship between testosterone and sarcopenia in older-adult men: a narrative review. J Clin Med 2022; 11: 6202.

[117] Samaras N , Samaras D , Frangos E , et al. A review of age-related dehy-droepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res 2013; 16: 285- 94.

[118] Du Y , Xu C , Shi H , et al. Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women. BMC Geriatr 2021; 21: 542.

[119] Guligowska A , Chrzastek Z , Pawlikowski M , et al. Gonadotropins at advanced age - Perhaps they are not so bad? Correlations between gonadotropins and sarcopenia indicators in older adults. Front Endocrinol 2021; 12: 797243.

[120] Sha T , Wang Y , Zhang Y , et al. Genetic variants, Serum 25-Hydroxyvitamin D Levels, and Sarcopenia: A Mendelian Randomization Analysis. JAMA Network Open 2023; 6: e2331558.

[121] Yoo JI , Chung HJ , Kim BG , et al. Comparative analysis of the association between various serum vitamin D biomarkers and sarcopenia. J Clin Lab Anal 2021; 35: e23946.

[122] Alsaawi TA , Aldisi D , Abulmeaty MMA , et al. Screening for sarcopenia among elderly Arab females: influence of body composition, lifestyle, Irisin, and Vitamin D. Nutrients 2022; 14: 1855.

[123] Nishikawa H , Asai A , Fukunishi S , et al. Metabolic syndrome and sarcopenia. Nutrients 2021; 13: 3519.

[124] Komici K , Dello Iacono A , De Luca A , et al. Adiponectin and Sarcopenia: a systematic review with meta-analysis. Front Endocrinol 2021; 12: 576619.

[125] Harada H , Kai H , Shibata R , et al. New diagnostic index for sarcopenia in patients with cardiovascular diseases. PLoS One 2017; 12: e0178123.

[126] Lin YL , Chen S-Y , Lai Y-H , et al. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin Nutr (Edinburgh, Scotland) 2020; 39: 2435- 41.

[127] Lian R , Liu Q , Jiang G , et al. Blood biomarkers for sarcopenia: a systematic review and meta-analysis of diagnostic test accuracy studies. Ageing Res Rev 2024; 93: 102148.

[128] Howard C , Ferrucci L , Sun K , et al. Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol (Bethesda, Md. : 1985) 2007; 103: 17- 20.

[129] Song YR , Kim JK , Lee HS , et al. Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients. BMC Nephrol 2020; 21: 281.

[130] Granic A , Hurst C , Dismore L , et al. Advanced glycation end products in skeletal muscle health and sarcopenia: a systematic review of observational studies. Mech Ageing Dev 2023; 209: 111744.

[131] Xiao C , Rajewsky K . MicroRNA control in the immune system: basic principles. Cell 2009; 136: 26- 36.

[132] Liu HC , Han DS , Hsu CC , et al. Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults. BMC Geriatr 2021; 21: 86.

[133] Fan Z , Yang JY , Guo Y , et al. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: Association with mitochondrial impairment. Exp Gerontol 2022; 163: 111802.

[134] Heymsfield SB , Gonzalez MC , Lu J , et al. Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc 2015; 74: 355- 66.

[135] Cawthon PM , Orwoll ES , Peters KE , et al; Osteoporotic Fractures in Men (MrOS) Study Research Group. Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men. J Gerontol A Biol Sci Med Sci 2019; 74: 844- 52.

[136] Khan J , Bath K , Hafeez F , et al. Creatinine excretion as a determinant of accelerated skeletal muscle loss with critical illness. Turk J Anaesthesiol Reanim 2018; 46: 311- 5.

[137] Siddharth J , Chakrabarti A , Pannérec A , et al. Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats. Aging (Milano) 2017; 9: 1698- 720.

[138] Enck P , Zimmermann K , Rusch K , et al. The effects of ageing on the colonic bacterial microflora in adults. Z Gastroenterol 2009; 47: 653- 8.

[139] Biagi E , Nylund L , Candela M , et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010; 5: e10667.

[140] Liu C , Cheung W-H , Li J , et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle 2021; 12: 1393- 407.

[141] Kang L , Li P , Wang D , et al. Alterations in intestinal microbiota diversity, composition, and function in patients with sarcopenia. Sci Rep 2021; 11: 4628.

[142] Ticinesi A , Mancabelli L , Tagliaferri S , et al. The Gut-Muscle Axis in older subjects with low muscle mass and performance: a proof of concept study exploring fecal microbiota composition and function with shotgun metagenomics sequencing.Int J Mol Sci 2020; 21: 8946.

[143] Liu X , Wu J , Tang J , et al. Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline. J Cachexia Sarcopenia Muscle 2023; 14: 2275- 88.

[144] Wang Y , Zhang Y , Lane NE , et al. Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study. J Cachexia Sarcopenia Muscle 2022; 13: 2340- 51.

[145] Zhou Q , Zhang H , Yin L , et al. Characterization of the gut microbiota in hemodialysis patients with sarcopenia. Int Urol Nephrol 2022; 54: 1899- 906.

[146] Margiotta E , Caldiroli L , Callegari ML , et al. Association of sarcopenia and gut microbiota composition in older patients with advanced chronic kidney disease, investigation of the interactions with uremic toxins, inflammation and oxidative stress. Toxins 2021; 13: 472.

[147] Ponziani FR , Picca A , Marzetti E , et al; GuLiver study group. Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia. Liver Int 2021; 41: 1320- 34.

[148] Ren X , Hao S , Yang C , et al. Alterations of intestinal microbiota in liver cirrhosis with muscle wasting. Nutrition (Burbank, Los Angeles County, Calif.) 2021; 83: 111081.

[149] Picca A , Ponziani FR , Calvani R , et al. Gut microbial, inflammatory and metabolic signatures in older people with physical frailty and sarcopenia: results from the BIOSPHERE Study. Nutrients 2019; 12: 65.

[150] Wu CS , Wei Q , Wang H , et al. Protective effects of ghrelin on fasting-induced muscle atrophy in aging mice. J Gerontol A Biol Sci Med Sci 2020; 75: 621- 30.

[151] Chen LH , Huang S-Y , Huang K-C , et al. Lactobacillus paracasei PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice. Aging (Milano) 2019; 11: 756- 70.

[152] Chen YM , Wei L , Chiu Y-S , et al. Lactobacillus plantarum TWK10 supplementation improves exercise performance and increases muscle mass in mice. Nutrients 2016; 8: 205.

[153] Huang WC , Hsu YJ , Huang CC , et al. Exercise training combined with Bifidobacterium longum OLP-01 supplementation improves exercise physiological adaption and performance. Nutrients 2020; 12: 1145.

[154] Lahiri S , Kim H , Garcia-Perez I , et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci Transl Med 2019; 11: eaan5662.

[155] Lee MC , Hsu Y-J , Ho H-H , et al. Lactobacillus salivarius Subspecies salicinius SA-03 is a new probiotic capable of enhancing exercise performance and decreasing fatigue. Microorganisms 2020; 8: 545.

[156] Soares ADN , Wanner SP , Morais ESS , et al. Supplementation with Saccharomyces boulardii increases the maximal oxygen consumption and maximal aerobic speed attained by rats subjected to an incremental-speed exercise. Nutrients 2019; 11: 2352.

[157] Ni Y , Yang X , Zheng L , et al. Lactobacillus and bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota. Mol Nutr Food Res 2019; 63: e1900603.

[158] Le Couteur DG , Solon-Biet SM , Cogger VC , et al. Branched chain amino acids, aging and age-related health. Ageing Res Rev 2020; 64: 101198.

[159] Gran P , Cameron-Smith D . The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes. BMC Physiol 2011; 11: 10.

[160] Yoshida T , Kakizawa S , Totsuka Y , et al. Effect of endurance training and branched-chain amino acids on the signaling for muscle protein synthesis in CKD model rats fed a low-protein diet. Am J Physiol Renal Physiol 2017; 313: F805- 14.

[161] Bai GH , Tsai MC , Tsai HW , et al. Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: a systematic review and meta-analysis. Eur J Nutr 2022; 61: 637- 51.

[162] Alkhalaf LM , Ryan KS . Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem Biol 2015; 22: 317- 28.

[163] Agus A , Planchais J , Sokol H . Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 2018; 23: 716- 24.

[164] Sanfilippo S , Imbesi RM , Sanfilippo S, Jr . Effects of a tryptophan deficient diet on the morphology of skeletal muscle fibers of the rat. Preliminary observations at neuroendocrinological and submicroscopical levels. Ital J Anat embryol= Archivio italiano di anatomia ed embriologia 1995; 100: 131- 41.

[165] Dukes A , Davis C , El Refaey M , et al. The aromatic amino acid tryptophan stimulates skeletal muscle IGF1/p70s6k/mTor signaling in vivo and the expression of myogenic genes in vitro. Nutrition (Burbank, Los Angeles County, Calif.) 2015; 31: 1018- 24.

[166] Morrison DJ , Preston T . Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut microbes 2016; 7: 189- 200.

[167] Frampton J , Murphy KG , Frost G , et al. Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat Metab 2020; 2: 840- 8.

[168] Lin R , Liu W , Piao M , et al. A review of the relationship between the gut microbiota and amino acid metabolism. Amino Acids 2017; 49: 2083- 90.

[169] Ryu D , Mouchiroud L , Andreux PA , et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 2016; 22: 879- 88.

[170] Pizzoferrato M , de Sire R , Ingravalle F , et al. Characterization of sarcopenia in an IBD population attending an Italian Gastroenterology Tertiary Center. Nutrients 2019; 11: 2281.

[171] Tschirner A , von Haehling S , Palus S , et al. Ursodeoxycholic acid treatment in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle 2012; 3: 31- 6.

[172] Kars M , Yang L , Gregor MF , et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010; 59: 1899- 905.

[173] Qiu Y , Yu J , Ji X , et al. Ileal FXR-FGF15/19 signaling activation improves skeletal muscle loss in aged mice. Mech Ageing Dev 2022; 202: 111630.

[174] Qiu Y , Yu J , Li Y , et al. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling. Ann Med 2021; 53: 508- 22.

[175] Benoit B , Meugnier E , Castelli M , et al. Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice. Nat Med 2017; 23: 990- 6.

[176] Fu L , John LM , Adams SH , et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004; 145: 2594- 603.

[177] Guo A , Li K , Xiao Q . Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK/PGC-1α pathway in skeletal muscle. Biochem Biophys Res Commun 2020; 526: 1069- 76.

[178] Morton GJ , Matsen ME , Bracy DP , et al. FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest 2013; 123: 4799- 808.

[179] Singh A , D'Amico D , Andreux PA , et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med 2022; 3: 100633.

[180] Daily JW , Park S . Sarcopenia is a cause and consequence of metabolic dysregulation in aging humans: effects of gut dysbiosis, glucose dysregulation, diet and lifestyle. Cells 2022; 11: 338.

[181] Egan AJF , Errington J , Vollmer W . Regulation of peptidoglycan synthesis and remodelling. Nat Rev Microbiol 2020; 18: 446- 60.

[182] Thome T , Salyers ZR , Kumar RA , et al. Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity. Am J Physiol Cell Physiol 2019; 317: C701- 13.

[183] Changchien CY , Lin Y-H , Cheng Y-C , et al. Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades. Chem Biol Interact 2019; 304: 43- 51.

RIGHTS & PERMISSIONS

2025 The Author(s). Published by Oxford University Press on behalf of Higher Education Press.